Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pharmaceutical statistics

Showing results (21-30 of 1,234) with videos related to

Pageof 124
Sort By:
Pharmaceutical Statistics|December 1, 2021
The power prior with multiple historical controls for the linear regression modelAkalu Banbeta, Emmanuel Lesaffre, Joost van Rosmalen
Pharmaceutical Statistics|July 17, 2019
Random effects models for estimation of the probability and time to progression of a continuous biomarkerTarylee Reddy, Geert Molenberghs, Liesbeth Bruckers, et al.
Pharmaceutical Statistics|July 17, 2019
Reference-based sensitivity analysis for time-to-event dataAndrew Atkinson, Michael G Kenward, Tim Clayton, et al.
Pharmaceutical Statistics|September 4, 2014
The shrinking or disappearing observed treatment effectChristy Chuang-Stein, Simon Kirby
Pharmaceutical Statistics|October 6, 2015
Model free audit methodology for bias evaluation of tumour progression in oncologyAndrew Stone, Euan Macpherson, Ann Smith, et al.
Pharmaceutical Statistics|November 13, 2015
Teaching examples for the design of experiments: geographical sensitivity and the self-fulfilling prophecyDennis W Lendrem, B Clare Lendrem, Ruth Rowland-Jones, et al.
Pharmaceutical Statistics|November 12, 2013
Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirementsRuud Boessen, Frederieke van der Baan, Rolf Groenwold, et al.
Pharmaceutical Statistics|March 28, 2012
Comments on 'Application of an adaptive design to a randomized phase II selection trial in gastric cancer: a report of the study design' by Satoshi Morita and Junichi Sakamoto. Pharmaceutical StatisticsMd Monir Hossain, Zhongxue Chen
Pharmaceutical Statistics|June 7, 2016
A modified varying-stage adaptive phase II/III clinical trial designGaohong Dong, Marc Vandemeulebroecke
Pharmaceutical Statistics|July 14, 2016
The analysis of incontinence episodes and other count data in patients with overactive bladder by Poisson and negative binomial regressionR Martina, R Kay, R van Maanen, et al.
Pageof 124

Showing results (21-30 of 1,234) with videos related to

Sort By:
Pageof 124
Pharmaceutical Statistics|December 1, 2021
The power prior with multiple historical controls for the linear regression modelAkalu Banbeta, Emmanuel Lesaffre, Joost van Rosmalen
Pharmaceutical Statistics|July 17, 2019
Random effects models for estimation of the probability and time to progression of a continuous biomarkerTarylee Reddy, Geert Molenberghs, Liesbeth Bruckers, et al.
Pharmaceutical Statistics|July 17, 2019
Reference-based sensitivity analysis for time-to-event dataAndrew Atkinson, Michael G Kenward, Tim Clayton, et al.
Pharmaceutical Statistics|September 4, 2014
The shrinking or disappearing observed treatment effectChristy Chuang-Stein, Simon Kirby
Pharmaceutical Statistics|October 6, 2015
Model free audit methodology for bias evaluation of tumour progression in oncologyAndrew Stone, Euan Macpherson, Ann Smith, et al.
Pharmaceutical Statistics|November 13, 2015
Teaching examples for the design of experiments: geographical sensitivity and the self-fulfilling prophecyDennis W Lendrem, B Clare Lendrem, Ruth Rowland-Jones, et al.
Pharmaceutical Statistics|November 12, 2013
Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirementsRuud Boessen, Frederieke van der Baan, Rolf Groenwold, et al.
Pharmaceutical Statistics|March 28, 2012
Comments on 'Application of an adaptive design to a randomized phase II selection trial in gastric cancer: a report of the study design' by Satoshi Morita and Junichi Sakamoto. Pharmaceutical StatisticsMd Monir Hossain, Zhongxue Chen
Pharmaceutical Statistics|June 7, 2016
A modified varying-stage adaptive phase II/III clinical trial designGaohong Dong, Marc Vandemeulebroecke
Pharmaceutical Statistics|July 14, 2016
The analysis of incontinence episodes and other count data in patients with overactive bladder by Poisson and negative binomial regressionR Martina, R Kay, R van Maanen, et al.
Pageof 124